14May
Biosimilar Buyouts: AbbVie Buyout of Allergan Receives Approval of Irish High Court; Gedeon Richter Buys Tocilizumab Biosimilar
On May 8, 2020, AbbVie announced that it completed its acquisition of Allergan plc, having received approval by the Irish High Court. AbbVie and Allergan had previously announced, on May 5, 2020, that the U.S. Federal Trade Commission accepted the...
By:
Goodwin
Source Url: https://www.jdsupra.com/legalnews/biosimilar-buyouts-abbvie-buyout-of-67063/
Related
In Liberty Mutual Fire Ins. Co. v. Fowlkes Plumbing., L.L.C., No. 2019-FC-10285-SCT, 2020 Miss. LEXI...
Read More >
It's no secret – protected conversation potentially admissible - The EAT decided in Harrison v Ary...
Read More >
As the Coronavirus (COVID-19) continues to disrupt travel and almost every other aspect of day-to-da...
Read More >
CBInsights recently hosted a webcast, The State of Healthcare Q2 2020. Capital raising by companies ...
Read More >
Every day, businesses large and small are seeking to be acquired, in whole or in part. (While such e...
Read More >
The Senate unanimously passed a hotly anticipated third COVID-19-related stimulus bill last night, a...
Read More >